Re. Goldsby et al., LYMPHOBLAST MORPHOLOGY IN PREDICTING LEUKEMIC MENINGEAL RELAPSE WITH LOW CHAMBER COUNT AND LYMPHOBLASTS, Medical and pediatric oncology, 29(2), 1997, pp. 98-102
The diagnostic criteria for meningeal relapse (MR) of acute lymphoblas
tic leukemia (ALL) are a cerebrospinal fluid (CSF) chamber count of mo
re than five leukocytes per microliter and a cytomorphological evaluat
ion revealing lymphoblasts. A dilemma arises when confronted with a pa
tient with a low CSF white blood cell (WBC) chamber count and lymphobl
asts. We utilized a scoring system to review lymphoblast morphology in
12 such patients. A cell was defined as a lymphoblast if it could not
be easily categorized as a lymphocyte, monocyte, histiocyte, or granu
locyte. Each lymphoblast was scored on four parameters: presence of nu
cleoli, homogeneous distribution of chromatin, nucleocytoplasmic ratio
greater than 75%, and nuclear irregularity. Cells were scored without
knowledge of the patients' out come. Seven patients eventually develo
ped MR by current criteria and five patients never relapsed. The mean
lymphoblast scores for patients that did and did not relapse were 2.35
and 1.53, respectively (P<.001). The percent of cells scored as lymph
oblasts was also significantly higher in patients that relapsed, 36.9%
vs. 19.4% (P=.01). Our study shows that careful cytomorphologic analy
sis can predict which patients with low chamber counts and ''blasts''
on cytocentrifuge examination will progress to meningeal relapse. We r
ecommend reviewing the definition of MR and using a scoring system whe
n confronted with blasts in a low chamber count cerebrospinal fluid sp
ecimen. (C) 1997 Wiley-Liss, Inc.